Trademark search for:

ENJILEV

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2003-02-24 — Application filed
2003-08-13 — Assigned to examiner
2003-08-14 — Examiners amendment e-mailed
2003-09-02 — Letter of suspension e-mailed
2003-09-02 — Paper received
2003-09-02 — Sec. 1(b) claim deleted
2003-09-02 — Correspondence received in law office
2003-09-25 — Approved for pub - principal register
2003-10-29 — Notice of publication
2003-11-18 — Published for opposition
2003-12-16 — Extension of time to oppose received
2004-01-21 — Opposition instituted no. 999999
2004-12-06 — Paper received
2007-04-30 — Opposition dismissed no. 999999
2007-04-30 — Opposition terminated no. 999999
2007-06-26 — Registered-principal register
2009-06-18 — Teas change of correspondence received
2014-01-31 — Cancelled sec. 8 (6-yr)
2014-01-31 — Final status recorded

Owner Information

Novartis AG
CH-4056 Basel CH

Correspondent

Maury M. Tepper, III Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh, NC 27609
UNITED STATES

Filing Details

Filing Date:
2003-02-24

Status Date:
2014-01-31

Category:
Pharmaceuticals

Filing Year:
2003

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.